跳至主要内容
临床试验/IRCT20201019049079N1
IRCT20201019049079N1招募中3 期

Investigating the effects of oral medium-chain triglyceride (MCT) on the process of disease symptoms in patients with viral respiratory tract infection in outpatients with metabolic syndrome

Kerman University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Informed consent
  • Metabolic Syndrome as defined by the International Diabetes Federation (IDF): Abdominal obesity above 94 cm in men and 80 cm in women plus two of the following criteria: IFG above 100, triglyceride above 150, HDL below 40 in men and below 50 in women And have systolic blood pressure above 130 mmHg or diastole above 85 mmHg
  • Symptoms of viral respiratory tract infection

排除标准

  • Drug allergy
  • Pregnancy / breastfeeding
  • Asthma and allergies
  • Immune system defects such as AIDS and corticosteroids

研究者

相似试验